Bio Key International Stock Revenue
| BKYI Stock | USD 1.73 0.38 18.01% |
BIO Key International fundamentals help investors to digest information that contributes to BIO Key's financial success or failures. It also enables traders to predict the movement of BIO Stock. The fundamental analysis module provides a way to measure BIO Key's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIO Key stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 8.9 M | 5 M |
BIO | Revenue |
BIO Key International Company Revenue Analysis
BIO Key's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current BIO Key Revenue | 7.75 M |
Most of BIO Key's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIO Key International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of BIO
Projected quarterly revenue analysis of BIO Key International provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of BIO Key match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in BIO Key's stock price.
BIO Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for BIO Key is extremely important. It helps to project a fair market value of BIO Stock properly, considering its historical fundamentals such as Revenue. Since BIO Key's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BIO Key's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BIO Key's interrelated accounts and indicators.
| 0.18 | -0.16 | -0.68 | 0.17 | 0.7 | ||
| 0.18 | 0.71 | -0.53 | 0.45 | 0.53 | ||
| -0.16 | 0.71 | -0.29 | 0.44 | 0.25 | ||
| -0.68 | -0.53 | -0.29 | -0.44 | -0.99 | ||
| 0.17 | 0.45 | 0.44 | -0.44 | 0.37 | ||
| 0.7 | 0.53 | 0.25 | -0.99 | 0.37 |
Click cells to compare fundamentals
BIO Revenue Historical Pattern
Today, most investors in BIO Key Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BIO Key's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BIO Key revenue as a starting point in their analysis.
BIO Key Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
BIO Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, BIO Key International reported 7.75 M of revenue. This is 99.78% lower than that of the Software sector and 99.05% lower than that of the Information Technology industry. The revenue for all United States stocks is 99.92% higher than that of the company.
BIO Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO Key's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO Key could also be used in its relative valuation, which is a method of valuing BIO Key by comparing valuation metrics of similar companies.BIO Key is currently under evaluation in revenue category among its peers.
BIO Key ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BIO Key's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BIO Key's managers, analysts, and investors.Environmental | Governance | Social |
BIO Key Institutional Holders
Institutional Holdings refers to the ownership stake in BIO Key that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BIO Key's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BIO Key's value.| Shares | Citadel Advisors Llc | 2024-06-30 | 0.0 | Abich Financial Wealth Management Llc | 2024-09-30 | 0.0 | Group One Trading, Lp | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 250 K | Virtu Financial Llc | 2024-09-30 | 14.8 K | Ubs Group Ag | 2024-09-30 | 6.3 K | Tower Research Capital Llc | 2024-09-30 | 5.2 K | Advisor Group Holdings, Inc. | 2024-09-30 | 262 | Jpmorgan Chase & Co | 2024-09-30 | 45.0 | Wells Fargo & Co | 2024-09-30 | 42.0 |
BIO Fundamentals
| Return On Equity | -4.58 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (1.45) % | ||||
| Current Valuation | 9.15 M | ||||
| Shares Outstanding | 3.11 M | ||||
| Shares Owned By Insiders | 5.57 % | ||||
| Shares Owned By Institutions | 5.02 % | ||||
| Number Of Shares Shorted | 300.42 K | ||||
| Price To Earning | (2.55) X | ||||
| Price To Book | 63.79 X | ||||
| Price To Sales | 1.13 X | ||||
| Revenue | 7.75 M | ||||
| Gross Profit | 3.44 M | ||||
| EBITDA | (7.85 M) | ||||
| Net Income | (8.52 M) | ||||
| Cash And Equivalents | 4.89 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 365.35 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.50 X | ||||
| Book Value Per Share | (0.58) X | ||||
| Cash Flow From Operations | (3.79 M) | ||||
| Short Ratio | 0.16 X | ||||
| Earnings Per Share | (8.66) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 43 | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 4.52 M | ||||
| Retained Earnings | (125.01 M) | ||||
| Working Capital | (591.23 K) | ||||
| Current Asset | 9.88 M | ||||
| Current Liabilities | 1.72 M | ||||
| Net Asset | 4.52 M |
About BIO Key Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO Key International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIO Key using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO Key International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out BIO Key Piotroski F Score and BIO Key Altman Z Score analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.